Results 111 to 120 of about 483,719 (279)

Validation of Addenbrooke’s cognitive examination III for detecting mild cognitive impairment and dementia in Japan

BMC Geriatrics, 2019
Background Early detection of mild cognitive impairment (MCI) and dementia is very important to begin appropriate treatment promptly and to prevent disease exacerbation.
Shintaro Takenoshita, Seishi Terada, Hidenori Yoshida, Megumi Yamaguchi, Mayumi Yabe, Nao Imai, Makiko Horiuchi, Tomoko Miki, Osamu Yokota, Norihito Yamada   +9 more
doaj   +1 more source

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer’s Disease [PDF]

, 2015
Background: The temporal relationship of cognitive deficit and functional impairment in Alzheimer’s disease (AD) is not well characterized. Recent analyses suggest cognitive decline predicts subsequent functional decline throughout AD progression ...
Baoguang Han, David Henley, Eric Siemers, Hong Liu-Seifert, Jeffrey Cummings, Joel Raskin, Karen Price, Karen Sundell, Katherine J. Selzler, null null, Paul Aisen, Richard Mohs   +11 more
core   +1 more source

Normal‐Appearing White Matter Injury Mediates Chronic Deep Venous Hypoxia and Disease Progression in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang, Huiying Wang, Zhizheng Zhuo, Ai Guo, Ke Lv, Decai Tian, Chao Chai, Yunyun Duan, Shuang Xia   +8 more
wiley   +1 more source

Using machine learning for detection of Parkinson's disease and mild cognitive impairment.

PLoS ONE
BackgroundParkinson's disease is a movement disorder featuring motor symptoms and cognitive decline, which can manifest as mild cognitive impairment. The incidence of mild cognitive impairment increases with disease progression, and Parkinson's disease ...
Anthaea-Grace Patricia Dennis, Sarah L Martin, Robert Chen, Philip Gerretsen, Antonio P Strafella   +4 more
doaj   +1 more source

MCI, en dan? De toekomst van 'mild cognitive impairment'

Tijdschrift voor Gerontologie en Geriatrie, 2014
Bespreking: Belleville, S., Gauthier, S., Lepage, E., Kergoat, M.J. & Gilbert, B. (2014). Predicting decline in mild cognitive impairment: a prospective cognitive study. Neuropsychology, 28, 643–652.
Han F.A. Diesfeldt
doaj   +1 more source

Dementia and mild cognitive impairment in prisoners aged over 50 years in England and Wales: a mixed-methods study

Health Services and Delivery Research, 2020
Background: People aged ≥ 50 years constitute the fastest-growing group in the prison population of England and Wales. This population has complex health and social care needs.
Katrina Forsyth, Leanne Heathcote, Jane Senior, Baber Malik, Rachel Meacock, Katherine Perryman, Sue Tucker, Rachel Domone, Matthew Carr, Helen Hayes, Roger Webb, Laura Archer-Power, Alice Dawson, Sarah Leonard, David Challis, Stuart Ware, Richard Emsley, Caroline Sanders, Salman Karim, Seena Fazel, Adrian Hayes, Alistair Burns, Mary Piper, Jenny Shaw   +23 more
doaj   +1 more source

The Differentiation of Amnestic Type MCI from the Non-Amnestic Types by Structural MRI [PDF]

, 2016
INTRODUCTION: While amnestic mild cognitive impairment (aMCI) and non-amnestic mild cognitive impairment (naMCI) are theoretically different entities, only a few investigations studied the structural brain differences between these subtypes of mild ...
András eHorváth, Enikő eSirály, Gábor eCsukly, Gábor eRudas, Pál eSalacz, Pál eSalacz, Zoltán eHidasi, Zsuzsanna eFodor, Ádám eSzabó, Éva eCsibri   +9 more
core   +2 more sources

Clinical Validation of Plasma p‐217tau in Neurological Diseases

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, Tetsuya Ueda, Seiji Kinoshita, Chikage Uchida, Takashi Sugawara, Kentaro Hashimoto, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji   +13 more
wiley   +1 more source

Bibliometric analysis of research trends on factors affecting older adults with mild cognitive impairment

Frontiers in Neurology
BackgroundIn recent years, the problem of cognitive impairment in the elderly has become increasingly prominent. Understanding the research trend of influencing factors of mild cognitive impairment, and provide reference for medical staff to early ...
Lei Yang, Rushi Yang, Bo Wang, Tiantian Liu, Ziyi Wang   +4 more
doaj   +1 more source

A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling, Mark D. Parker, Sven Kerst, Richard A. Pasternack, Jacob Tondreau, Marjolein Breur, Gemma M. van Rooijen‐van Leeuwen, Davide Tonduti, Ettore Salsano, Alejandra Darling, Joanna A. E. van Wijk, Susanna Törnroth‐Horsefield, Marianna Bugiani, Petra J. W. Pouwels, Quinten Waisfisz, Marjo S. van der Knaap, Rogier Min   +16 more
wiley   +1 more source